These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22234927)

  • 1. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects.
    Caudevilla-Gálligo F; Riba J; Ventura M; González D; Farré M; Barbanoj MJ; Bouso JC
    J Psychopharmacol; 2012 Jul; 26(7):1026-35. PubMed ID: 22234927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration.
    Carmo H; de Boer D; Remião F; Carvalho F; dos Reys LA; de Lourdes Bastos M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(2):143-52. PubMed ID: 15522713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market.
    Giroud C; Augsburger M; Rivier L; Mangin P; Sadeghipour F; Varesio E; Veuthey JL; Kamalaprija P
    J Anal Toxicol; 1998 Sep; 22(5):345-54. PubMed ID: 9737327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.
    Páleníček T; Fujáková M; Brunovský M; Horáček J; Gorman I; Balíková M; Rambousek L; Syslová K; Kačer P; Zach P; Bubeníková-Valešová V; Tylš F; Kubešová A; Puskarčíková J; Höschl C
    Psychopharmacology (Berl); 2013 Jan; 225(1):75-93. PubMed ID: 22842791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.
    van der Gouwe D; Brunt TM; van Laar M; van der Pol P
    Addiction; 2017 Apr; 112(4):640-648. PubMed ID: 27936283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature.
    Cole MD; Lea C; Oxley N
    Sci Justice; 2002; 42(4):223-4. PubMed ID: 12632938
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions.
    González D; Torrens M; Farré M
    Biomed Res Int; 2015; 2015():643878. PubMed ID: 26543863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of 4-bromo-2,5-dimethoxyphenethylamine abuser's urine: identification and quantitation of urinary metabolites.
    Kanamori T; Nagasawa K; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
    J Forensic Sci; 2013 Jan; 58(1):279-87. PubMed ID: 23066942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration.
    Rohanová M; Pálenícek T; Balíková M
    Toxicol Lett; 2008 Apr; 178(1):29-36. PubMed ID: 18339493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.
    Habrdova V; Peters FT; Theobald DS; Maurer HH
    J Mass Spectrom; 2005 Jun; 40(6):785-95. PubMed ID: 15827969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans.
    Nugteren-van Lonkhuyzen JJ; van Riel AJ; Brunt TM; Hondebrink L
    Drug Alcohol Depend; 2015 Dec; 157():18-27. PubMed ID: 26530501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of use and subjective effects of Salvia divinorum among recreational users.
    González D; Riba J; Bouso JC; Gómez-Jarabo G; Barbanoj MJ
    Drug Alcohol Depend; 2006 Nov; 85(2):157-62. PubMed ID: 16720081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry.
    Theobald DS; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):374-7. PubMed ID: 16978931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity involving the hallucinogenic designer amines MDA and 2C-I.
    Drees JC; Stone JA; Wu AH
    J Forensic Sci; 2009 Nov; 54(6):1485-7. PubMed ID: 19878416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal mephedrone intoxication--a case report.
    Adamowicz P; Tokarczyk B; Stanaszek R; Slopianka M
    J Anal Toxicol; 2013; 37(1):37-42. PubMed ID: 23134715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA: interactions with other psychoactive drugs.
    Mohamed WM; Ben Hamida S; Cassel JC; de Vasconcelos AP; Jones BC
    Pharmacol Biochem Behav; 2011 Oct; 99(4):759-74. PubMed ID: 21756931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Toxicology of 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): The Severity of Poisoning After Exposure to Low to Moderate and High Doses.
    Nugteren-van Lonkhuyzen JJ; de Lange DW; van Riel AJHP; Vrolijk RQ; Ohana D; Hondebrink L
    Ann Emerg Med; 2020 Sep; 76(3):303-317. PubMed ID: 32507489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
    Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
    Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.